SCHULHOFF & CO INC

Position in CTMX — CytomX Therapeutics, Inc.

CIK 1080197 CINCINNATI, OH

Position in CTMX

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$2,244,485

+$647,624 QoQ

Shares Held

477,550

+27.4% QoQ

Ownership

0.219%

of shares outstanding

% of Portfolio

1.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

SCHULHOFF & CO INC holds $2,775,219 across 3 Biotechnology names. CTMX ranks #1 (80.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CTMX	CytomX Therapeutics, Inc. This page	477,550	$2,244,485
2	SPRY	ARS Pharmaceuticals, Inc.	51,150	$410,734
3	FATE	Fate Therapeutics Inc	100,000	$120,000

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,244,485	477,550	+27.4%	Shares	Sole	2026-05-11
2025-12-31	$1,596,861	374,850	—	Shares	Sole	2026-02-11
No filing history on record for this holder in this stock.